InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Roundtable: The second medical use challenge – full transcript

James Nurton, London


Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London

This is the full, unabridged, transcript of the discussion, which was held on January 18 this year at the office of Bristows in London, and was moderated by Managing IP’s James Nurton. The views expressed are those of the participants...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Yohan Liyanage of Linklaters says the Australian concept of "hottubbing" of experts "is something that has just com… https://t.co/1WOz8PtP6K

Dec 8 2017 09:48 ·  reply ·  retweet ·  favourite
ManagingIP profile

Nokia’s Adrian Howes discussing Huawei v ZTE in panel on FRAND and SEPs. “One of the big things coming out of the C… https://t.co/9qqJX1WIpR

Dec 8 2017 05:49 ·  reply ·  retweet ·  favourite
ManagingIP profile

Maximillian Haedicke of University of Freiburg reveals the equivalent of tea leaf reading in Germany is called coff… https://t.co/GNi9hYfKa4

Dec 8 2017 03:18 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements